Clinical Trials on Overweight in Colombia
Total 144 results
-
Orexigen Therapeutics, IncCompleted
-
Hospices Civils de LyonActive, not recruitingObesity, MorbidFrance
-
Novo Nordisk A/SCompletedOverweight or Obesity | Metabolism and Nutrition DisorderUnited States, India, Mexico, Russian Federation, United Kingdom, Canada, Denmark, Finland, Belgium, Japan, Taiwan, France, Poland, Germany, Bulgaria, Argentina, Puerto Rico
-
Novo Nordisk A/SNot yet recruitingObesityUnited Kingdom, Germany, Canada, United States, France
-
Orexigen Therapeutics, IncCompletedObesity | OverweightUnited States
-
Laval UniversityTakeda; InnovairTerminatedChronic Obstructive Pulmonary Disease | Metabolic SyndromeCanada
-
Inversago Pharma Inc.Active, not recruitingObesity | Metabolic SyndromeCanada
-
University of Missouri-ColumbiaAmerican Society for Metabolic and Bariatric SurgeryRecruitingHypertension | Diabetes Mellitus | Metabolic Syndrome | Morbid Obesity | Obstructive Sleep Apnea of AdultUnited States
-
GI DynamicsBiostatistical Consulting, Inc.Recruiting
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States, Italy, Spain, Canada, Hungary
-
HealthCore-NERINational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Western University, CanadaCanadian Institutes of Health Research (CIHR); Public Health Agency of Canada...CompletedObesity | OverweightCanada, United States
-
Columbia UniversityAmerican Cancer Society, Inc.; Gabrielle's Angel FoundationActive, not recruitingAcute Lymphoblastic Leukemia, Pediatric | Obesity, PediatricUnited States
-
Bristol-Myers SquibbTerminatedHypertensionSweden, United States, Puerto Rico, Hungary, Colombia
-
Boehringer IngelheimCompletedObesityBelgium, Australia, Sweden, United States, Canada, Germany, Korea, Republic of, China, Netherlands, New Zealand, United Kingdom, Poland
-
Rhythm Pharmaceuticals, Inc.Enrolling by invitationHypothalamic ObesityUnited States, Canada, Japan, United Kingdom, Germany, Netherlands
-
Novo Nordisk A/SCompletedObesity | OverweightGermany, Denmark, Canada, United States, Russian Federation, Finland, Poland, France, Japan
-
Novo Nordisk A/SRecruitingObesityUnited States, Australia, Japan
-
Novo Nordisk A/SActive, not recruitingObesityUnited States, Czechia, Germany, Canada, Hungary, Portugal, Norway, South Africa, Poland, Greece, Bulgaria, Slovakia
-
PfizerTerminatedObesityUnited States, Australia, Canada, Brazil, Slovakia, Czech Republic, Argentina, Germany, Mexico, United Kingdom, Sweden
-
Eli Lilly and CompanyRecruitingOverweight and ObesityUnited States, Australia, Italy, Hungary, Spain, Canada, Germany, Argentina, Belgium, Czechia, Greece, Israel, Austria, Brazil, Mexico, Netherlands, Romania, India, United Kingdom, Slovakia, Poland, Turkey, Puerto Rico, France, Denmark
-
Hospices Civils de LyonNot yet recruitingObesity | Sarcopenic Obesity | Bariatric Surgery | Binge Eating Disorder | Psychotropic Drugs | Syndromic Obesity | Iatrogenic ObesityFrance
-
Novo Nordisk A/SCompletedObesitySpain, United States, France, Russian Federation, Canada, Colombia, South Africa, Norway, Denmark, Saudi Arabia, Sweden
-
Eli Lilly and CompanyCompletedSchizophrenia | Schizoaffective DisorderUnited States
-
Novo Nordisk A/SCompletedObesityUnited Kingdom, Canada, Denmark, Finland, Spain
-
Novo Nordisk A/SActive, not recruitingObesityFinland, Spain, Taiwan, Korea, Republic of, United States, Netherlands, India, Japan, United Kingdom, Germany, Serbia, Denmark, Canada, Bulgaria, Australia, South Africa, Italy, Poland, Mexico, Belgium, Turkey, France, Argentina
-
Eli Lilly and CompanyRecruitingCardiovascular Diseases | ObesityUnited States, Australia, Mexico, Spain, Canada, Hungary, Argentina, Puerto Rico, Poland, Slovakia
-
Orexigen Therapeutics, IncTerminated
-
Boehringer IngelheimActive, not recruitingObesityUnited States, Korea, Republic of, Belgium, Australia, China, Poland, Japan, Finland, Germany, Canada, Netherlands, New Zealand, Sweden, United Kingdom
-
Eli Lilly and CompanyActive, not recruitingObesity | OverweightSpain, United States, Australia, Italy, Hungary, India, Israel, Canada, China, Taiwan, Japan, United Kingdom, Belgium, France, Germany, Mexico, Romania, Poland, Argentina, Brazil, Puerto Rico, Austria, Turkey, Netherlands, Korea, Republic... and more
-
IDeA States Pediatric Clinical Trials NetworkNational Institutes of Health (NIH)CompletedVitamin D Deficiency | Asthma | Pediatric ObesityUnited States
-
Mount Sinai Hospital, CanadaCanadian Institutes of Health Research (CIHR); Sunnybrook Research InstituteRecruitingDiabetes Mellitus, Type 2 | Child Development | Child Obesity | Pregnancy in DiabeticCanada, Australia
-
Novo Nordisk A/SCompletedObesity | Metabolism and Nutrition DisorderUnited States, India, Israel, Italy, United Kingdom, Spain, France, Sweden, Taiwan, Turkey, Germany, South Africa, Puerto Rico
-
PfizerCompleted
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States, France, Spain, Taiwan, United Kingdom, Germany, India, Brazil, Canada, Japan, Malaysia, Russian Federation, Australia, Norway, Mexico, Netherlands, Portugal, Hungary, Italy, Austria, Greece, South Africa, Turkey, Finland, Puerto Rico and more
-
Novo Nordisk A/SRecruitingCardiovascular DiseaseNetherlands, Australia, Italy, United States, Serbia, Malaysia, Spain, United Kingdom, Thailand, India, Turkey, Mexico, Canada, Bulgaria, Argentina, Germany, France, Poland, South Africa, Brazil, Colombia, Denmark, Ireland, Japan
-
PfizerTerminatedObesity | Diabetes MellitusUnited States, Hungary, Canada, Japan, Poland, Puerto Rico, Bulgaria, Czechia
-
Boehringer IngelheimRecruitingObesityUnited States, Korea, Republic of, Belgium, Australia, United Kingdom, Mexico, Spain, Germany, Taiwan, Netherlands, Brazil, Hungary, Denmark, Canada, Poland, Austria, China, Finland, Greece, Italy, Hong Kong, Czechia, Portugal, Saudi... and more
-
Novo Nordisk A/SActive, not recruitingObesity | Diabetes Mellitus, Type 2United States, Canada, Hungary, Portugal, Slovakia, South Africa, Poland, Bulgaria
-
Rhythm Pharmaceuticals, Inc.CompletedObesity | Genetic Obesity | Obesity Due to Melanocortin 4 Receptor DeficiencyUnited States, United Kingdom, Germany, Netherlands, France, Canada, Greece, Israel, Spain
-
Boehringer IngelheimRecruitingObesity | Diabetes Mellitus, Type 2United States, Korea, Republic of, Belgium, Spain, China, Australia, Hungary, Canada, Czechia, Poland, New Zealand, Denmark, Finland, Germany, Greece, Netherlands, Sweden, Japan, United Kingdom
-
Novo Nordisk A/SCompletedObesity | Metabolism and Nutrition DisorderUnited States, Poland, Israel, Italy, Mexico, Spain, Canada, Denmark, Finland, United Kingdom, France, Netherlands, Austria, Belgium, Argentina, Russian Federation, Serbia, Turkey, Switzerland, Germany, South Africa, Hungary, Hong Kong and more
-
Novo Nordisk A/SActive, not recruitingObesity | Overweight | Type 2 Diabetes MellitusUnited States, India, Poland, Malaysia, United Kingdom, Japan, Thailand, Germany, Austria, Canada, Hungary, Ireland, Puerto Rico
-
Eisai Inc.Thrombolysis In Myocardial Infarction (TIMI) Academic Research OrganizationCompletedObesity | Cardiovascular Disease | Overweight | Type 2 Diabetes | High Cardiovascular RiskUnited States, Canada, Poland, Australia, Mexico, New Zealand, Bahamas, Chile